STALICLA
PrivateLast Round
VC Round
Jun 30, 2025
Total Funding Raised
$49.86M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
STALICLA is a biopharmaceutical company that develops precision medicine for neurodevelopmental and neuropsychiatric disorders using its proprietary DEPI platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STALICLA Comparables
Compare STALICLA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alto Neuroscience | 77% | |
| Itay & Beyond | 76% | |
| Insilico Medicine | 76% | |
STALICLA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2025 | ||||
| Series B | Jan 16, 2024 | ||||
| Series A | Feb 3, 2020 | ||||
| Seed | Jun 30, 2018 |
Key People
Founding team and executive leadership
STALICLA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4see ventures | Series A |
| Akilia Partners | Seed, Series B, Series A |
| SPRIM Global Investments | Series B |
| Forestay Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 52% MoM.
- Feb 7, 2026
Grew 19% QoQ, from 21 to 25 employees.
STALICLA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about STALICLA's valuation, stock price, and market status.